Genetic polymorphisms affecting nitric oxide and ß-cytokine pathways may contribute to increased COVID-19 mortality in schizophrenia.

Papadopoulos, Konstantinos I; Sutheesophon, Warachaya; Aw, Tar-Choon

Papadopoulos, Konstantinos I; Sutheesophon, Warachaya; Aw, Tar-Choon.

Papadopoulos KI; Department of Research and Development, THAI StemLife, Bangkok 10310, Thailand. Electronic address: kostas@thaistemlife.co.th.
Sutheesophon W; Laboratory Department, THAI StemLife, Bangkok 10310, Thailand.
Aw TC; Department of Laboratory Medicine, Changi General Hospital, Singapore 529889, Singapore; Department of Medicine, National University of Singapore, Singapore 119228, Singapore.

Asian J Psychiatr ; 69: 102981, 2022 03.

Article in English | MEDLINE | ID: covidwho-1588385

Subject(s)

COVID-19; Schizophrenia; Cytokines/genetics; Humans; Nitric Oxide/metabolism; Polymorphism, Genetic; SARS-CoV-2; Schizophrenia/genetics

Keywords

CSF2RB; ENOS; RAAS; SARS-CoV-2; Schizophrenia; ßcR

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Schizophrenia / COVID-19 Limits: Humans Language: English Journal: Asian J Psychiatr Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google